- Drug Repositioning in Glioblastoma: A Pathway Perspective
Sze Kiat Tan et al, 2018, Front. Pharmacol. CrossRef - Emerging therapeutic potential of anti-psychotic drugs in the management of human glioma: A comprehensive review
Muhamad N.A. Kamarudin et al, 2019, Oncotarget CrossRef - CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide
Richard E. Kast et al, 2014, Oncotarget CrossRef - Fluoxetine, an antidepressant, suppresses glioblastoma by evoking AMPAR-mediated calcium-dependent apoptosis
Kao-Hui Liu et al, 2015, Oncotarget CrossRef - A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care
Richard E. Kast et al, 2013, Oncotarget CrossRef - Effect of Selected Anionic and Cationic Drugs Affecting the Central Nervous System on Electrical Properties of Phosphatidylcholine Liposomes: Experiment and Theory
Joanna Kotyńska et al, 2021, IJMS CrossRef - Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery—A Comprehensive Review of the Literature
Safwan Alomari et al, 2021, Biomolecules CrossRef - Complex Effects of Sertraline and Citalopram on In Vitro Murine Breast Cancer Proliferation and on In Vivo Progression and Anxiety Level
Michal Taler et al, 2022, IJMS CrossRef - Antidepressant Drug Sertraline against Human Cancer Cells
Diana Duarte et al, 2022, Biomolecules CrossRef - Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia
Timothy Johanssen et al, 2023, Front. Oncol. CrossRef - SOX7 inhibits tumor progression of glioblastoma and is regulated by miRNA-24
Chen Xiuju et al, 2016 CrossRef - Navigating glioblastoma complexity: the interplay of neurotransmitters and chromatin
Jessica Romero-Reyes et al, 2024, Mol Biol Rep CrossRef - Antidepressants as additional drugs for human brain gliomas
A.V. Revishchin et al, 2024, Burdenko's Journal of Neurosurgery CrossRef